Aura Biosciences reported total assets of $348.13M and total liabilities of $32.86M for the quarter ended Jun 2026, up 70.3% year over year. This balance sheet covers 24 quarters of results from Sep 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||||
| Current Assets | ||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 81.83M | 149.06M | 108.38M | 53.85M | 61.11M | 121.58M | 38.49M | 47.73M | 55.58M | 41.06M | 26.28M | 30.07M | 25.41M | 31.69M | 38.23M | 107.37M | 47.55M | 59.52M | 84.79M | 67.84M | ||||
| Cash & Current Investments | 81.83M | 149.06M | 108.38M | 53.85M | 61.11M | 121.58M | 38.49M | 47.73M | 55.58M | 41.06M | 26.28M | 30.07M | 25.41M | 31.69M | 38.23M | 107.37M | 47.55M | 59.52M | 84.79M | 67.84M | ||||
| Prepaid Assets | 1.61M | 4.62M | 6.28M | 5.51M | 4.21M | 7.87M | 5.58M | 4.18M | 4.81M | 5.62M | 9.38M | 8.18M | 9.10M | 9.53M | 6.53M | 6.65M | 8.25M | 5.50M | 3.77M | 5.19M | ||||
| Current Assets | 83.46M | 153.70M | 139.58M | 127.67M | 115.91M | 196.70M | 179.12M | 166.21M | 153.89M | 231.79M | 212.25M | 195.60M | 183.48M | 160.62M | 134.52M | 183.96M | 170.12M | 149.74M | 118.50M | 329.03M | ||||
| Non-Current Assets | ||||||||||||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 4.44M | 5.25M | 5.91M | 5.80M | 5.47M | 5.37M | 5.17M | 5.06M | 4.86M | 3.15M | 3.05M | 3.33M | 3.33M | 3.21M | 3.11M | 2.86M | 2.63M | 2.62M | 2.47M | 2.20M | ||||
| Other Non-Current Assets | 0.12M | 0.12M | 0.12M | 0.89M | 0.77M | 0.77M | 0.77M | 0.77M | 0.77M | 0.77M | 0.77M | 0.77M | 0.77M | 0.77M | 0.77M | 0.77M | 0.77M | 0.77M | 0.77M | 1.14M | ||||
| Non-Current Assets | 7.25M | 6.33M | 6.84M | 7.35M | 27.24M | 27.23M | 26.90M | 26.53M | 25.88M | 23.28M | 22.78M | 22.69M | 21.86M | 21.88M | 20.88M | 20.44M | 19.90M | 19.69M | 19.17M | 19.10M | ||||
| Assets | 90.70M | 160.03M | 146.42M | 135.02M | 143.15M | 223.94M | 206.02M | 192.74M | 179.77M | 255.07M | 235.03M | 218.28M | 205.34M | 182.50M | 155.40M | 204.40M | 190.02M | 169.43M | 137.68M | 348.13M | ||||
| Liabilities | ||||||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||||||
| Accounts Payables | 1.74M | 2.40M | 1.96M | 1.20M | 1.72M | 2.92M | 1.05M | 0.55M | 1.49M | 1.79M | 1.93M | 1.46M | 1.99M | 2.30M | 2.01M | 1.29M | 1.89M | 1.55M | 2.57M | 2.25M | ||||
| Payables | 1.74M | 2.40M | 1.96M | 1.20M | 1.72M | 2.92M | 1.05M | 0.55M | 1.49M | 1.79M | 1.93M | 1.46M | 1.99M | 2.30M | 2.01M | 1.29M | 1.89M | 1.55M | 2.57M | 2.25M | ||||
| Accumulated Expenses | 3.49M | 4.34M | 2.42M | 3.98M | 5.30M | 4.57M | 4.07M | 5.33M | 6.37M | 7.88M | 4.99M | 6.33M | 9.60M | 9.46M | 6.99M | 10.37M | 13.71M | 13.59M | 10.87M | 14.01M | ||||
| Other Accumulated Expenses | 1.18M | 1.69M | 1.05M | 1.59M | 2.19M | 1.54M | 2.22M | 2.47M | 2.43M | 3.44M | 2.51M | 2.30M | 4.17M | 3.39M | 3.35M | 5.45M | 7.14M | 7.01M | 7.54M | 8.26M | ||||
| Current Leases | 0.61M | 0.61M | 0.62M | 0.63M | 2.94M | 2.96M | 2.98M | 3.01M | 3.04M | 2.69M | 2.74M | 2.75M | 3.13M | 3.15M | 3.17M | 3.20M | 3.22M | 3.24M | 3.27M | 3.29M | ||||
| Total Current Liabilities | 5.83M | 7.36M | 5.00M | 5.81M | 9.96M | 10.46M | 8.11M | 8.89M | 10.89M | 12.36M | 9.66M | 10.55M | 14.71M | 14.91M | 12.16M | 14.85M | 18.82M | 18.38M | 16.71M | 19.56M | ||||
| Non-Current Liabilities | ||||||||||||||||||||||||
| Non-Current Deffered Revenue | ||||||||||||||||||||||||
| Preferred Stock Liabilities | 80.25M | |||||||||||||||||||||||
| Operating Leases | 0.51M | 0.36M | 0.21M | 0.05M | 18.13M | 17.89M | 17.65M | 17.41M | 17.15M | 16.87M | 16.58M | 16.28M | 15.96M | 15.62M | 15.27M | 14.92M | 14.53M | 14.13M | 13.72M | 13.30M | ||||
| Other Non-Current Liabilities | 0.07M | 0.08M | 0.13M | 0.07M | ||||||||||||||||||||
| Total Non-Current Liabilities | 6.34M | 7.63M | 5.21M | 5.86M | ||||||||||||||||||||
| Total Liabilities | 6.42M | 7.71M | 5.34M | 5.93M | 28.09M | 28.35M | 25.76M | 26.30M | 28.05M | 29.23M | 26.24M | 26.83M | 30.67M | 30.53M | 27.43M | 29.77M | 33.36M | 32.52M | 30.43M | 32.86M | ||||
| Shareholder's Equity | ||||||||||||||||||||||||
| Common Equity | -131.01M | 152.31M | 141.09M | 129.09M | 115.05M | 195.58M | 180.26M | 166.44M | 151.72M | 225.85M | 208.78M | 191.45M | 174.67M | 151.97M | 127.97M | 174.63M | 156.67M | 136.91M | 107.25M | 315.27M | ||||
| Liabilities and Shareholders Equity | 90.70M | 160.03M | 146.42M | 135.02M | 143.15M | 223.94M | 206.02M | 192.74M | 179.77M | 255.07M | 235.03M | 218.28M | 205.34M | 182.50M | 155.40M | 204.40M | 190.02M | 169.43M | 137.68M | 348.13M | ||||
| Treasury Shares | 102.67M | 6.92M | ||||||||||||||||||||||
| Retained Earnings | -140.50M | 304.45M | 306.06M | 307.66M | 309.54M | 406.56M | 408.67M | 413.32M | 417.03M | 512.62M | 515.78M | 518.99M | 522.45M | 525.93M | 529.57M | 603.33M | 611.46M | 617.43M | 621.56M | 914.77M |